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resistance to mycobacterial infection
Introduction
Protective immunity to Mycobacterium tuberculosis infec-
tion, both in humans and experimental animals, is regu-
lated by T cells, macrophages and cytokines, which
include interferon-c (IFN-c), interleukin-12 (IL-12) and
tumour necrosis factor (TNF).
1,2 IFN-c derived from T
and natural killer (NK) cells has been shown to be essen-
tial, as mice with a disruption of the IFN-c system are
unable to restrict the growth of M. tuberculosis and suc-
cumb to the infection.
3–6
A critical role for TNF in mycobacterial defence is
inferred from neutralization and deletion experiments
in mice.
3–8 In addition, the TNF-related cytokine
lymphotoxin-a, (LTa, previously known as TNF-b), has
also been shown to be required to control mycobacte-
rial infection.
9 Secreted TNF and LTa signal both
through the p55 and p75 TNF receptors, TNFR1 and
TNFR2 respectively, while the cell bound LTab hetero-
trimer recognize the LTbR.
10 TNFR1 signalling appears
to be critical for the control of mycobacterial infec-
tion
5,8 while a role of TNFR2 is not excluded.
11 LTbR
signalling was similarly found to protect against myco-
bacterial infection
12,13
TNF is produced by macrophages, but is expressed by a
variety of cells and is a major regulator of inﬂammation
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Summary
Tumour necrosis factor-a (TNF-a) plays a critical role in the recruitment
and activation of mononuclear cells in mycobacterial infection. The role
of membrane TNF, in host resistance against Mycobacterium bovis bacille
Calmette–Gue ´rin (BCG), was tested in knock-in mice in which the endo-
genous TNF was replaced by a non-cleavable and regulated allele (D1–12,
TNF
tm/tm). While 100% of mice with complete TNF deﬁciency (TNF
)/))
succumbed to infection, 50% of TNF
tm/tm mice were able to control
M. bovis BCG infection and survived the experimental period. Membrane
expressed TNF allowed a substantial recruitment of activated T cells and
macrophages with granuloma formation and expression of bactericidal
inducible nitric oxide synthase (iNOS). Using virulent Mycobacterium
tuberculosis infection we conﬁrm that membrane TNF conferred partial
protection. Infection in TNF
tm/tm double transgenic mice with TNF-R1 or
TNF-R2 suggest protection is mediated through TNF-R2 signalling. There-
fore, the data suggest that membrane-expressed TNF plays a critical role
in host defence to mycobacterial infection and may partially substitute for
soluble TNF.
Keywords: BCG; granuloma; H37Rv; membrane D1-12 TNF; Mycobacte-
rium; T-cell recruitment; TNF-deﬁciency
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14,15 Although a key role of
TNF in controlling intracellular bacterial infections is
uncontested, the function of membrane TNF, which is
subsequently cleaved by the metalloproteinase-disintegrin
TACE (TNF-a converting enzyme
16) into the secreted tri-
meric TNF is, in mycobacterial host resistance, less clear.
Several biological functions of membrane TNF have
been described, such as cytotoxicity, polyclonal activation
of B cells, and induction of IL-10 by monocytes and intra-
cellular adhesion molecule-1 expression on endothelial
cells.
17–19 The transgenic expression of membrane TNF
demonstrated an in vivo role including the control of BCG
and M. tuberculosis infection
20–22 but this approach is
imperfect as the transgenic expression of high levels mem-
brane TNF is artiﬁcial and may cause altered immune
responses and non-physiological pathology. As an example
the spontaneous development of arthritis in transgenic
mice expressing mutant membrane TNF was directly
attributed to the deregulation of membrane TNF produc-
tion.
23 Two novel mutants have been generated where the
endogenous TNF was either replaced by a D1-9,K11E TNF
allele
24 or D1-12 allele,
25 which represent a major advance
allowing interesting insights in the role of membrane TNF
in lymphoid structure development and inﬂammation.
We and others demonstrated that the D1-9,K11E mutant
has enhanced resistance to M. tuberculosis
26,27 and Listeria
monocytogenes infection.
28 D1-12 TNF mutant is resistant
to low-dose L. monocytogenes infection, but no data are
available on mycobacterial infections.
25
Here, we demonstrated that the D1-12 TNF mutant
25 is
partially resistant to infection with 50% of mice that suc-
cumb to the non-virulent vaccine strain Mycobacterium
bovis BCG, while 100% of TNF-deﬁcient mice succumb
to infection. TNF
tm/tm mice were able to recruit and acti-
vate macrophages and T cells, and generate mycobacteri-
cidal granuloma in response to M. bovis BCG infection.
However, resistance to the virulent M. tuberculosis strain
was less pronounced, suggesting substantial differences
between this and the D1-9,K11E mouse mutant.
24
Methods
Animals
Adult, 8- to 10-week-old female mice of the wild type
(WT) strain C57BL/6, homozygous D1-12 TNF mutant
25
(TNF
tm/tm), TNFR1
)/),T N F R 2
)/) and TNF
)/)29 strains, all on
a C57BL/6 genetic background were bred and maintained
under speciﬁc pathogen-free conditions. TNF
tm/tm mice
were crossed on TNFR1
)/) mice
30 or TNFR2
)/) mice
31 in
order to study the signalling of membrane TNF. The geno-
types of the mouse populations were conﬁrmed by poly-
merase chain reaction (PCR) analysis of tail biopsies. PCR
primers: D1-12 TNF mutant – 50-TAATGGGCAGGGCAA
GGTGG-30 and 50-TTCACTTCCGGTTCCTGCACCCT-30;
TNFR1 – 50-CTCTCTTGTGATCAGCACTG -30,5 0-TCCC
GCTTCAGTGACAACGTC-30 and 50-AGAAATCTCAAG
ACAATTCTCTGC-30; TNFR2 – 50-CCTCTCATGCTGT
CCCGGAAT-30,5 0-AGCTCCAGGCACAAGGGCGGG-30,
50-CGGTTCTTTTTGTCAAGAC-30 and 50-ATCCTCGCC
GTCGGGCATGC-30. All protocols employed in this study
were approved by the University of Cape Town Research
Ethics Committee.
Mycobacteria
M. tuberculosis H37Rv (Trudeau Mycobacterial Culture
Collection; Trudeau Institute, Saranac Lake, NY) and
M. bovis Bacille Calmette–Gue ´rin (BCG) (Prof. G. Marchal,
Pasteur Institute, Paris) were grown in Middlebrook 7H9
medium (Difco Laboratories, Detroit, MI), supplemented
with 10% oleic acid albumin dextrose catalase (OADC)
(State Vaccine Institute, Cape Town, South Africa) and
0 5% glycerol (Merck, Darmstadt, Germany) in 5% CO2
at 37  and frozen in aliquots. Prior to use, an aliquot
was thawed, brieﬂy vortexed, diluted in sterile saline and
clumping disrupted by aspirating through a 29-gauge needle
(Omnican ; Braun, Melsungen AG, Germany) 20 times.
Mycobacterial infection
WT, TNF
tm/tm and TNF-deﬁcient mice were injected
intravenously (i.v.) at an infective dose of 2 · 10
6 BCG.
Groups consisted of 10 mice and the experiments were
repeated twice. Mice were killed at 2, 4 and 8 weeks after
infection. For the aerosol infection mice were infected
with 30 viable CFU of H37Rv via the aerosol route using
an inhalation exposure system (Glas-Col, Terre Haute, IN).
Lipopolysaccharide (LPS)/D-galactosamine (D-Gal)-
induced septic shock
LPS (Escherichia coli, serotype O111:B4; Sigma, St Louis,
MO) with D-Gal (Sigma) was injected intraperitoneally
(i.p.) to induce systemic TNF and endotoxic shock as
described previously.
32 Brieﬂy, mice were injected i.p.
with 10 lg of LPS in combination with 20 mg D-Gal.
Mice were monitored for 24 hr and the number of
moribund mice was recorded.
Histology and immunohistochemistry
Lungs were removed and weighed. The organs were ﬁxed
in 4% buffered formalin, or frozen on dry ice and main-
tained at )80 . Two to 5 lm-thick sections of the lungs
were cut and stained with either haematoxylin and eosin
or Ziehl–Neelsen for acid-fast bacilli. Formalin-ﬁxed, par-
afﬁn-embedded sections were de-parafﬁnized and
re-hydrated through decreasing concentrations of alcohol
as described.
7 Sections were stained with a rabbit
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synthase (iNOS; obtained from J. Pfeilschifter, University
of Frankfurt, Germany). Sections were then washed in
phosphate-buffered saline (PBS) and incubated for
30 min at room temperature with biotinylated rat anti-
rabbit serum followed by Vectastain ABC system (Vector
Laboratories Inc., Burlingame, CA) and 3,30-diamino-
benzidine (DAB) substrate. Finally, sections were mounted
in Immunomount (Shandon, Pittsburgh, PA).
Colony-forming units (CFU)
Bacterial loads in the lung, liver and spleen of infected
mice were evaluated at 2, 4 and 8 weeks post-infection.
Organs were weighed and deﬁned aliquots were homo-
genized in saline containing 0 04% Tween-80. Tenfold
serial dilutions of organ homogenates were plated in
duplicates onto Middlebrook 7H10 agar plates containing
10% OADC (Difco). Plates were incubated at 37  for 19–
21 days and colonies counted. Data are expressed as mean
CFU per organ.
Bronchoalveolar lavage
Under anaesthesia a 20-gauge catheter (Introcan, B.
Braun, Melsungen AG, Germany) was inserted into the
exposed trachea. The lungs were lavaged with two vol-
umes of 300 ll PBS. Lavage ﬂuid was centrifuged at
405 g for 5 min, the supernatant was removed, aliquoted
and stored at )80  for cytokine and chemokine analysis.
Lungs were subsequently lavaged with four volumes of
800 ll PBS. To remove traces of red blood cells, pooled
samples were incubated in 1 ml red cell lysis buffer for
5 min, washed twice with 5 ml PBS. Samples were centri-
fuged at 405 g for 5 min and the cells were used for ﬂow
cytometric analysis. Procedures were performed under
sterile conditions and samples kept on ice for the dura-
tion of the experiment.
Cytological analysis
Teﬂon coated, eight-well (6 mm) multi-well slides (High-
veld Biological, Lyndhurst, South Africa) were used for
cytospins. A 100 llo fa2  5 · 10
5 cells/ml cell suspension
was pipetted into each well and the liquid was drained
from the well by attached Whatman ﬁlter paper. The slide
was left to air dry overnight at room temperature. The
cells were stained with RapiDiff staining kit, after removal
of the ﬁlter paper, for differential cell counting. Unstained
slides were stored at )20 , wrapped in aluminium foil.
Cells were stained by immersing the slides three times
(±5 s) in the following solutions: RapiDiff ﬁxative, Rapi-
Diff solution 1 (eosin in phosphate buffer) RapiDiff solu-
tion 2 (haematoxylin) and a ﬁnal rinse in distilled H2O.
Slides were left to dry for 1–2 hr at room temperature
and mounted with entellan (Merck). Routinely, 100 cells
per cytospin, in duplicate, per mouse were differentiated
in a random fashion.
Flow cytometry
Cells (1 · 10
6) were incubated with 25 ll ﬂuorescence-
activated cell sorting (FACS) blocking solution for
30 min after which they were washed with 1 ml FACS
buffer and centrifuged at 405 g for 5 min. Cells were
incubated with 2 lg/ml anti-CD3 phycoerythrin (PE;
clone 145-2C11) and either 2 lg/ml anti-CD4
ﬂuoroscein isothiocyanate (FITC; clone H129-19) or
2 lg/ml anti-CD8 FITC (clone 53-6-7) in a total
volume of 50 ll for 30 min. Cells were washed with
1 ml FACS buffer, centrifuged at 405 g for 5 min and
resuspended in FACS ﬁxation buffer. Samples were kept
on ice for the duration of the labelling procedure.
Fluorescently labelled antibodies were purchased
from BD Pharmingen (San Diego, CA). Samples were
analysed on a FACSCalibur (Beckton Dickinson, San
Jose, CA) ﬂowcytometer using Cell Quest software.
Primary bone-marrow-derived macrophage (BMDM)
cultures and infection
Mice 6–8 weeks old were killed and the femurs and tibia
removed aseptically as described before by Mu ¨ller et al.
33
The bone marrows were ﬂushed out with ice-cold DMEM
(Dulbecco’s modiﬁed Eagle’s minimal essential medium
with 4500 mg/l glucose, L-glutamine and 25 mM HEPES
without sodium bicarbonate) using a syringe ﬁtted with
a 29-gauge needle. The cells eluted were resuspended
in DMEM supplemented with 30% L929 conditioned
medium and 20% horse serum and plated at a concentra-
tion of 2 · 10
6 cells/10 ml in Sterilin 90-mm bacterio-
logical plates. On day 10, cells were pooled, pelleted by
centrifugation and plated at 3 · 10
5 cells/well in a 48-well
plate (Costar; Corning Incorporated, Corning, NY). Cells
were stimulated with 10 lg/ml LPS (Escherichia coli,
serotype O111:B4; Sigma-Aldrich, St Louis, MO) and
100 U/ml rIFN-c (BD Pharmingen) for 72 hr. In the
infection study, the cells were prestimulated with
100 U/ml rIFN-c for 16 hr and infected with M. bovis
BCG (multiplicity of infection = 1:2) and the superna-
tants collected after 54 hr.
Enzyme-linked immunosorbent assay (ELISA) assay
TNF, IFN-c and IL-12, IL-4, IL-5, monocyte chemoattrac-
tant protein-1 (MCP-1) and RANTES (regulated on activa-
tion, normal, T-cell expressed, and secreted) in supernatant
of bronchoalveolar lavage ﬂuid (BALF) were measured by
ELISA with a sensitivity of <15 pg/ml (R&D Systems,
Abingdon, UK and BD Pharmingen, San Diego, CA).
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Statistical evaluation of differences between the experi-
mental groups was determined by the use of the Student’s
t-test and ANOVA with a level of signiﬁcance of P <0  05.
Results
Absence of secreted TNF in TNF
tm/tm mice
To conﬁrm that TNF
tm/tm knock-in mice do not secrete
TNF, mice were injected i.p. with 100 lg LPS and blood
was collected after 90 min and serum analysed by ELISA.
In contrast to WT mice that displayed signiﬁcant serum
TNF levels, TNF was undetectable in the sera of both
TNF
)/) and TNF
tm/tm mice (Fig. 1a). In addition, we
showed that D-Gal sensitized WT mice were susceptible to
LPS and succumbed from TNF-induced endotoxic shock
after 24 hr as shown previously,
32 whereas TNF
tm/tm mice
survived the endotoxic shock as did the TNF
)/) mice
(Table 1).
We then investigated whether cultured BMDM could
secrete TNF in response to LPS or after M. bovis BCG
infection. Our results show that TNF was secreted by
BMDM from WT mice, but undetectable in culture
supernatants of BMDM from TNF
tm/tm and TNF
)/) mice
(Fig. 1b).
Furthermore, membrane expression of TNF was found
to be inducible upon stimulation.
25 Taken together, these
observations conﬁrm the absence of secreted TNF in
TNF
tm/tm mice as previously described.
25
TNF
tm/tm mice are more resistant to M. bovis BCG
infection than TNF-deﬁcient mice
To determine whether membrane-bound TNF contributes
to protective immunity, a comparative study was per-
formed to determine the susceptibility of TNF
tm/tm,
TNF
)/) and WT mice to mycobacterial infection. Groups
of 10 mice per strain were i.v. infected with 2 · 10
6 CFU
of the non-virulent vaccine strain M. bovis BCG and the
rate of mortality was recorded. Within 3–4 weeks of
infection TNF
)/) mice displayed rapid weight loss
(Fig. 2a), impeded locomotor activity and succumbed to
infection between 5 and 8 weeks (Fig. 2b). Although
TNF
tm/tm mice manifested weight loss during the early
phase of infection, the weights stabilized, and about 50%
of the TNF
tm/tm mice survived the experiment. All WT
mice survived the infection. From these observations, we
concluded that membrane-bound TNF confers partial
protection to systemic BCG infection in the absence of
secreted TNF.
Membrane TNF mice induce partial protective
immunity to pulmonary M. bovis BCG infection
We and others have shown previously that the elimina-
tion of mycobacteria from the lung is absolutely depen-
dent on TNF, while evidence for bacterial clearance from
the liver and spleen in a TNF-dependent and -indepen-
dent manner after systemic infection was reported.
3,4,7
The importance of membrane-bound TNF for the control
of mycobacterial growth in the lung was therefore
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Figure 1. Absence of soluble TNF after endotoxin or mycobacterial
stimulation. (a) In vivo injection of 100 lg LPS i.p. in TNF
tm/tm
mice, TNF
)/) mice and WT mice, serum was taken at 90 min and
analysed for TNF by ELISA. (b) LPS and BCG induced TNF at 4 hr
in the supernatant of cultured macrophages. Data are expressed as
the mean ± SD (n = 4 mice). ND, not detected.
Table 1. Susceptibility of WT, TNF
tm/tm and TNF
)/) mice to LPS/
d-Gal
Strain Moribund mice
WT 5/5
TNF
tm/tm 0/5
TNF
)/) 0/5
WT, wild type; TNF, tumour necrosis factor.
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tm/tm, TNF
)/) mice and WT mice
infected i.v. with 2 · 10
6 CFU M. bovis BCG. Macro-
scopic pathology of the lungs in TNF
)/) mice was charac-
terized by the presence of large nodular lesions on the
pleura at 4 weeks post-infection which augmented in size
and became conﬂuent at 8 weeks post-infection. Lesions
were found also in TNF
tm/tm mice at 4 and 8 weeks post-
infection, but were much smaller and more discrete, while
WT mice displayed minor lesions (Fig. 3a). As a surrogate
marker of inﬂammation we used lung weights. The lung
weights were increased in both TNF
tm/tm and TNF
)/)
mice at 8 weeks, while the lung weights of WT mice were
unchanged (Fig. 3b). However, TNF
tm/tm mice had signif-
icantly lower lung weights than TNF
)/) mice (P <0  05)
suggesting partial protection from pulmonary infection.
We then determined the mycobacterial growth and
elimination in the lungs over 8 weeks. All three mouse
strains had similar bacilli levels (CFU) in the lungs
2 weeks after infection (Fig. 3c). At 4 weeks, WT mice
displayed a small increase of CFU, but were thereafter
able to eliminate the mycobacteria.
By contrast, bacilli burden was higher at 4 weeks in
both TNF
tm/tm mice and TNF
)/) mice (P <0  01) than in
WT mice. TNF
)/) mice displayed uncontrolled myco-
bacterial growth with a signiﬁcant increment in CFU in
the lung at 8 weeks as compared to the 4 week values
(P <0  05). In contrast to TNF
)/) mice, TNF
tm/tm mice
were able to control infection at 8 weeks. CFU in lungs of
TNF
tm/tm at 8 weeks were lower than at 4 weeks
(P <0  05). In addition, CFU in the lungs of TNF
tm/tm
mice were signiﬁcantly lower than that of TNF
)/) mice
(P <0  05). Therefore, the data demonstrate that the sole
presence of membrane-bound TNF is able to control
M. bovis BCG infection in 50% of mice.
Membrane TNF allows the expression of pulmonary
granuloma
The establishment of granulomas is the manifestation of a
vigorous cell-mediated immune response, which is crucial
for inhibiting mycobacterial growth. A critical role of
TNF for initiating and maintaining the structural integrity
of granulomas has been demonstrated.
3 We therefore
asked whether membrane TNF is sufﬁcient for granuloma
formation upon M. bovis BCG infection.
Pulmonary pathology in all three mouse strains at
2 weeks post-infection was characterized by areas that
had normal alveolar and focal thickened septa, but the
alveolar spaces were free from inﬁltrations (Fig. 4a) and
there was no difference between the groups. At 4 weeks
post-infection the lungs of WT mice displayed well-
deﬁned granulomatous lesions that were characterized by
foamy epithelioid-like macrophages with surrounding and
interspersed lymphocytes and prominent perivascular
lymphocytic inﬁltration. At 8 weeks WT mice, which con-
trol M. bovis BCG infection, showed evidence of resolving
granulomatous lesions.
As expected, TNF
)/) mice showed further thickening of
septae containing inﬂammatory cells at 4 weeks, but did
not develop granulomatous lesions and only sparse peri-
vascular lymphocytic inﬁltration. At 8 weeks, a prominent
perivascular and peribronchial lymphocyte inﬁltration was
found in TNF
)/) mice. There was, however, no structural
organization of the inﬁltrating lymphocytes and macro-
phages into a well-structured granuloma, and an
increased recruitment of neutrophils was apparent.
In contrast, TNF
tm/tm mice displayed typical, but small
granulomas at 4 weeks post-infection, which were less
well demarcated than those found in WT mice. Epitheloid
macrophages and lymphocytes were distinguishable and
perivascular lymphocyte recruitment was evident. These
early granulomas developed into enlarged pulmonary
lesions at 8 weeks post-infection.
In addition, Ziehl–Neelsen staining revealed that bacilli
in both WT and TNF
tm/tm mice are less abundant and
predominantly conﬁned to granulomas at 4 weeks and
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Figure 2. Survival of TNF
tm/tm and TNF
)/) mice infected with
Mycobacterium bovis BCG. Body weight change (a) and survival
(b) of TNF
tm/tm (D), TNF-deﬁcient mice (s) and WT mice (d)
infected i.v. with 2 · 10
6 BCG bacilli and monitored for 3 months.
Each group comprised 10 mice.
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)/) mice with the
absence of properly deﬁned granulomas the bacilli were
dispersed in the tissue and predominantly extracellular
(Fig. 4b). Therefore, in contrast to complete TNF deﬁ-
ciency the sole presence of membrane-bound TNF
allowed a substantial granulomatous response with bacte-
ricidal properties.
Membrane TNF allows partial cellular recruitment
upon mycobacterial infection
In view of the granulomatous response elicited in
TNF
tm/tm mice after M. bovis BCG infection we investi-
gated the cellular recruitment in the lungs. Cells from
BAL were obtained at 2 and 4 weeks post-infection. WT
mice showed signiﬁcant recruitment of macrophages,
lymphocytes and neutrophils into the BALF 2 and
4 weeks after infection. The total cell number was highest
in WT mice, followed by TNF
tm/tm and TNF KO mice,
which had signiﬁcantly reduced total cell recruitment
(P <0  05) at 4 weeks (Fig. 5a). The macrophage recruit-
ment in BALF was signiﬁcantly reduced in TNF
tm/tm and
TNF KO mice (P <0  05) (Fig. 5b), while the lymphocyte
counts (Fig. 5c) showed only a trend of reduction and
the neutrophils (Fig. 5d) were elevated, but not different
among the experimental groups at 4 weeks.
CD4
+ and CD8
+ T cells are critical for the generation
of cell-mediated immunity. We therefore investigated
whether membrane-bound TNF is sufﬁcient to recruit
speciﬁc T-cell subsets. Cells from BAL at 4 weeks post-
infection were analysed by ﬂow cytometry. In the pres-
ence of both soluble and secreted TNF (WT mice), effec-
tive recruitment of CD3
+ CD4
+ T cells and CD3
+ CD8
+
T cells occurred (Fig. 6a). In the absence of TNF, T-cell
recruitment was reduced sevenfold (CD3
+ CD4
+ T cells:
21% versus 3% and CD3
+ CD8
+ T cells: 6% versus
0 8%). By contrast, the sole expression of membrane-
bound TNF was sufﬁcient to allow a signiﬁcant recruit-
ment of CD4 and CD8 T cells in BALF of TNF
tm/tm mice,
which was only 2–3 · lower than in WT mice
(CD3
+ CD4
+ T cells: 21% versus 8% and CD3
+ CD8
+ T
cells: 6% versus 2%).
In addition, we investigated the activation status of the
recruited T cells. We found that >95% of the cells
recruited were activated, as deﬁned by the high expression
of CD11a and CD44, and there was no difference among
the three groups (Fig. 6b).
As the T-cell recruitment was reduced in BAL, we
asked whether the inﬂammatory response in the lungs of
BCG-infected mice differed in the total or partial absence
of TNF. As shown in Fig. 4, TNF
tm/tm, but not TNF
)/)
mice were able to recruit abundant lymphocytes and
macrophages into the lung tissue allowing the formation
of granulomas, which were, however, less well developed
than in WT mice. We asked whether the partial recruit-
ment of lymphocytes as shown in BALF was sufﬁcient to
support macrophage activation. We measured iNOS as an
indicator of macrophage activation, semiquantitavely and
observed expression in TNF
tm/tm mice, but at a lower level
compared with WT mice. However, iNOS expression in
WT
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Figure 3. Lung pathology and uncontrolled bacterial growth in TNF
)/) mice. TNF
tm/tm mice (D), TNF
)/) mice (s) and WT mice (d) were
infected i.v. with 2 · 10
6 BCG M. bovis BCG. (a) Macroscopic lung changes in BCG infected mice at 2, 4 and 8 weeks post-infection. (b) Lung
weights of BCG infected mice at 2, 4 and 8 weeks post-infection. (c) Bacterial load (CFU) was determined in lungs after 2, 4 and 8 weeks after
BCG infection (2 · 10
6 BCG i.v.). The results are expressed as the mean ± SD of ﬁve mice.
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Membrane TNF controls mycobacterial infectionTNF
tm/tm mice was substantially higher than in TNF
)/)
mice (Fig. 7).
These data suggest that membrane TNF allows substan-
tial recruitment of T cells and the activation of macro-
phages resulting in mycobactericidal effector mechanisms,
which are largely absent with complete TNF deﬁciency.
Membrane TNF enables cytokine and chemokine
secretion
We next investigated the secretion of cytokines and chemo-
kines in BALF as possible factors that inﬂuences cellular
recruitment and protective immunity. Chemokine expres-
c
4 weeks 8 weeks  2 weeks
WT
TNFtm/tm
TNF–/–
a b
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f e d
g hi
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Figure 4. Histopathology in lungs of M. bovis BCG infected TNF
tm/tm mice, TNF
)/) mice and WT mice. Mice (ﬁve mice per group)were killed
at 2, 4 and 8 weeks post-infection and the sections stained with haematoxylin and eosin (a) (400·) or with Ziehl–Neelsen (b) (1000·) to detect
the acid-fast bacilli.
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part TNF dependent.
14,34–36 We therefore investigated the
contribution of membrane-bound TNF in the generation
of the T helper 1 (Th1)-deﬁning cytokines, IFN-c and
IL-12, the Th2 cytokines, IL-4 and IL-5, and the mono-
cyte and lymphocyte chemoattractants MCP-1 and RAN-
TES in BAL.
Levels of IL-12 at 4 weeks post-infection were signiﬁ-
cantly higher in TNF
tm/tm mice in comparison with WT
mice or TNF
)/) mice (Fig. 8a). IFN-c secretion was low in
WT mice and highest in TNF
tm/tm mice (Fig. 8a). As
expected, no TNF could be detected in TNF
tm/tm and
TNF
)/) mice and MCP-1 was undetectable at 4 weeks (not
shown). RANTES levels peaked at 4 weeks post-infection in
WT mice and were signiﬁcantly (P   0 01) reduced at
8 weeks post-infection in WT mice (Fig. 8b). TNF
tm/tm and
TNF
)/) mice displayed elevated levels at 8 weeks post-
infection (P   0 01). We were unable to detect the secre-
tion of IL-4 or IL-5 during any stage of the infection.
The high level of IFN-c and IL-12 at 4 weeks, and
RANTES at 8 weeks post-infection in TNF
tm/tm mice sug-
gest a strong Th1 response, which was conﬁrmed by an
enhanced cutaneous delayed-type reaction in infection in
both TNF
tm/tm and TNF
)/) mice (data not shown). The
higher levels of RANTES in TNF
)/) mice might be related
to the high bacterial burden in the lung.
Membrane TNF generates partial protective immunity
against M. tuberculosis aerosol infection
In order to determine whether the partial protective
immune response that was generated after the infection
with M. bovis BCG is applicable during a virulent infection,
mice were infected with a low dose (10–30 CFU/lung) of
M. tuberculosis H37Rv by aerosol inhalation. Body weight
ratios were determined for 7 weeks of infection and the
groups were scored for mortality. Progressive infection was
paralleled by continual lowering of body weight ratios and
mortality in TNF
)/) mice (Fig. 9a,b). In contrast, WT mice
and TNF
tm/tm did not show a loss of body weight during
the early course of infection. After 8 weeks of infection,
 80% of TNF
tm/tm mice were still alive, while all TNF
)/)
mice had succumbed to fatal pulmonary tuberculosis.
We further assessed the mycobacterial burden in the
lung of M. tuberculosis-infected mice. While TNF
)/) mice
displayed an uncontrolled infection with signiﬁcantly
increased CFU already at 4 weeks (P <0  05), the TNF
tm/tm
mice showed at least a partial control of mycobacterial
growth, with CFU values signiﬁcantly less (P <0  05) than
TNF
)/) mice at 45 days (Fig. 10a). CFU counts in liver
and spleen, as a measure of the systemic dissemination of
M. tuberculosis, were signiﬁcantly higher in TNF
tm/tm and
TNF
)/) mice 45 days post-infection than in WT (Fig. 10a).
However, the hepatic CFU in TNF
tm/tm mice were lower
(P <0  05) than that of TNF
)/) mice.
Lastly, we asked whether the protective effect of mem-
brane TNF is signalled through TNFR1 or TNFR2. There-
fore, we generated double transgenic mice by crossing
TNF
tm/tm mice with TNFR1
)/) or TNFR2
)/) mice. We
further assessed the mycobacterial burden in the lung of
M. tuberculosis infected mice. In this experiment, TNF
)/)
mice lost weight rapidly and died within 5 weeks, while
TNF
tm/tm mice were less sensitive, half surviving up to
45 days. TNF
tm/tm · TNFR2 KO mice seemed essentially
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Figure 5. Cellular recruitment in bronchoalveo-
lar space in the lungs of M. bovis BCG-infected
TNF
tm/tm mice, TNF
)/) mice and WT mice.
BALF was collected from TNF
tm/tm (line bar),
TNF-deﬁcient mice (open bar) and WT mice
(black bar) infected i.v. with 2 · 10
6 BCG bacilli
at 2, 4 and 8 weeks. Cells (200 cells/mouse)
were stained using a Rapidiff staining kit (Clini-
cal Sciences Diagnostics, Southdale, South
Africa), the average differential cell count were
analysed in triplicate and recorded as previously
described.
45 Mean values ± SD of total cell
counts (a), macrophages (b), lymphocytes (c)
and neutrophils (d) are given (n = 5).
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Membrane TNF controls mycobacterial infectionas sensitive as TNF
)/) mice, while TNF
tm/tm · TNFR1
KO mice behaved more like TNF
tm/tm mice (Fig. 11a).
Therefore, signalling of membrane TNF through TNF-R2
likely confers protection. This hypothesis is further cor-
roborated by increased mycobacterial loads in the lung
of TNF
tm/tm · TNFR2 KO at 6 weeks post-infection, a
time point when all TNF
)/) had succumbed, essentially
doubled as compared to TNF
tm/tm or TNF
tm/tm · TNFR1
KO mice (Fig. 11b).
Therefore, the sole expression of membrane TNF pro-
vided partial protection against H37Rv infection and the
data using the double transgenic mice indicate that mem-
brane TNF signalling through TNF-R2 confers the protec-
tive effect of membrane-bound TNF.
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Figure 6. Reduced pulmonary recruitment of CD4 and CD8 T cells in TNF
tm/tm mice and TNF
)/) mice. BALF was collected from M. bovis BCG-
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strain. (a) Recruitment of CD4 and CD8 T cells in WT, TNF
tm/tm and TNF
)/) mice. (b) Expression of CD11a and CD44 on CD4 and CD8 cells
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)/) mice.
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Here we demonstrated that the D1-12 TNF mutant,
25
which expresses only membrane TNF is partially resistant
to infection to the non-virulent vaccine strain M. bovis
BCG with 50% of mice surviving the experimental period,
while all TNF-deﬁcient mice succumb to infection.
TNF
tm/tm mice were able to recruit and activate macro-
phages and T cells and generate mycobactericidal granu-
loma in response to BCG infection. However, resistance
to the virulent M. tuberculosis strain was less pronounced,
suggesting substantial differences between this and the
D1-9,K11E mouse mutant.
24 This TNF mutant differs
from the D1-9,K11E TNF allele
24 in several aspects – the
lymphoid structure especially is abnormal. We and others
demonstrated that the D1-9,K11E mutant has enhanced
resistance to M. tuberculosis infection
26,27 and Listeria
infection.
28
A critical role of TNF for the effective control and reso-
lution of mycobacterial infection has been demonstrated
previously.
4,7,35 Further, TNFR1-mediated signalling is
required for generating protective immunity against
mycobacterial infection,
5 which is probably more impor-
tant than TNFR2 signalling.
11 TNF provided by recombi-
nant BCG expressing TNF may reconstitute granuloma
formation and host response in TNF
)/), but not in
TNFR1
)/) mice, demonstrating the critical role of TNF
and TNFR1 signalling.
37
The partial protection that is generated in TNF
tm/tm
mice could indicate local cell-to-cell TNF signalling by
membrane expressed TNF on T cells or macrophages at
the site of infection leading to a partial activation of the
immune cells. Several biological functions of membrane
TNF have been reported previously and a preferential
TNFR2 signalling has been suggested in vitro
19,38 and
in vivo
21,38,39 using transgenic mice expressing membrane
TNF. The present data therefore suggest a functional role
of TNFR2 in host protection. Furthermore, membrane
TNF has been shown to be involved in reverse (outside-
to-inside) signalling. Upon ligation of its receptor mem-
brane-bound TNF-expressing cells are activated to express
E-selectin.
40 Thus, membrane-bound TNF, at least in T
cells, might function as a bipolar positive regulator of
inﬂammation either transmitting signals as a ligand to
WT
TNFtm/tm
TNF–/–
Figure 7. Reduced expression of iNOS in lungs of BCG-infected
TNF
tm/tm mice and TNF
)/) mice at 4 weeks post-infection. Lung
sections were incubated with iNOS antibody as described. Magniﬁca-
tion 100·.
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Figure 8. Cytokine and chemokine secretion in BALF of TNF
tm/tm
mice (line bar), TNF
)/) mice (open bar) and WT mice (black bar).
(a) IFN-c and IL-12 were measured at 28 days, and (b) RANTES
was analysed at 28 and 56 days. The results are expressed as the
mean ± SD (n = 4).
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Membrane TNF controls mycobacterial infectiontarget cells or receiving signals through membrane TNF
itself into T cells.
Although the exact mechanism of how protection is
acquired through membrane TNF is unclear, membrane
TNF on activated T cells might be sufﬁcient for partial
activation of macrophages; this results in the upregulation
of iNOS expression, which is crucial for bacterial kill-
ing.
21,41–43 Membrane TNF expressed on T cells might
replace secreted TNF to form granulomas in TNF
tm/tm
mice. Macrophage and lymphocyte recruitment was sig-
niﬁcantly reduced in TNF
)/) mice, with a signiﬁcant
reduction of the CD3
+ CD4
+ and CD3
+ CD8
+ T-cell sub-
sets in the absence of TNF, which might be related to
reduced chemokine production in the absence of TNF.
14
As the recruitment of the different cell types was partially
restored in TNF
tm/tm mice, membrane TNF on T cells or
other cells might provide a partial signal for chemokine
induction and hence increased cell trafﬁcking. The contri-
bution of CD4
+ T-cells in cell-mediated immunity against
mycobacteria has been investigated by the use of neutral-
izing antibodies and gene-deﬁcient mice.
1 In the absence
of CD4
+ typical granuloma formation in T cells was
largely absent.
44
However, in view of the only partial activation and
protection, which is likely caused by direct cell–cell con-
tact, secreted TNF and hence distal signalling, appears to
be required for a full protective host response. This ﬁnd-
ing concurs with the recent data demonstrating reduced
severity of autoimmune encephalomyelitis, but little effect
on inﬂammation in the spinal cord in a similar genetic
mouse model.
24
Lastly, the infection studies in double TNF
tm/tm
· TNFR1 or R2
)/) transgenic mice rescued protection in
TNF
tm/tm · TNFR2
)/) mice and comparable protection in
TNF
tm/tm · TNFR1
)/) mice as in TNF
tm/tm mice suggest
that membrane signalling though TNFR2 likely provides
host protection. Our data in this infection model using the
D1-12 TNF mutant mouse shows a reduced protective
immune response during mycobacterial infection when
compared to previous ﬁndings in which a membrane TNF
transgenic mutant or the D1-9,K11E mutant were used.
Our ﬁndings indicate that membrane TNF, in the D1-12
TNF mutant may preferentially induce protection through
TNFR2. Receptor signalling in membrane TNF transgenic
mutant or the D1-9,K11E mutant may be mediated
through both TNFR1 and TNFR2 different, accounting
for the differences observed in the degree of protection
afforded by membrane TNF in the different mutant
strains.
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N. Allie et al.The data suggest that sparing membrane expressed
TNF in therapeutic interventions neutralizing TNF such
as in rheumatoid arthritis might reduce infectious com-
plications. In summary, we show that membrane TNF
participates in cell-mediated immunity against myco-
bacterial infection. The protective effect of membrane-
bound TNF is likely mediated through TNFR2 signalling.
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